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Events occurring in early life may affect 
cardiovascular health across the life course 
(Barker and Bagby 2005). For example, sub­
optimal growth in utero is associated with 
accelerated weight gain in children during 
childhood and greater risk of later hyper­
tension, cardiovascular disease (CVD), and 
diabetes (Bagby 2007; Huxley et al. 2000). 
Little is known about how other prenatal 
insults, such as exposure to environmental 
toxicants, may also affect subsequent chil­
dren’s risks of such conditions.
Lead is a ubiquitous environmental pollut­
ant that accumulates in the human body, nota­
bly in bone, after exposure. Developmental 
toxicity of lead has recently emerged as a 
potentially large public health problem because 
substantial mobilization of maternal skeletal 
lead stores occurs during pregnancy (Hu 1998; 
Tellez­Rojo et al. 2004) and because the fetus 
is particularly vulnerable to environmental 
toxicants (Grandjean et al. 2008). Prenatal 
lead exposure has been linked, for example, 
to intrauterine growth restriction and neu­
rodevelopmental toxicity (Cory­Slechta et al. 
2008; Gomaa et al. 2002; Gonzalez­Cossio 
et al. 1997; Hernandez­Avila et al. 2002).
Although adult lead exposure is an estab­
lished risk factor for hypertension and CVD in 
adults (Korrick et al. 1999; Nash et al. 2003; 
Navas­Acien et al. 2007; Weisskopf et al. 
2009), less is known about the lead–blood 
pressure (BP) association in children (Chen 
et al. 2006; Factor­Litvak et al. 1996; Gump 
et al. 2005). Because childhood BP is an estab­
lished precursor of hypertension and CVD in 
adults (Lauer and Clarke 1989), studying the 
relationship of early­life environmental expo­
sures to childhood BP may shed light on the 
development of adult hypertension.
A previous longitudinal study reported a 
positive association between umbilical cord 
blood lead, a commonly used surrogate for 
prenatal exposure, and BP during childhood 
(Gump et al. 2005). However, the timing of 
fetal dose remains unclear, because cord lead 
mostly represents fetal exposure just before 
delivery and not throughout the entire preg­
nancy. Furthermore, although numerous stud­
ies have found sex differences in the association 
between markers of prenatal insults and BP 
(Gilbert and Nijland 2008; Jones et al. 2008; 
Loos et al. 2001; Taylor et al. 1997; te Velde 
et al. 2004), sex­specific susceptibility to lead 
in the developmental programming of cardio­
vascular regulation has not yet been examined. 
Indeed, gonadal hormones and sex­linked 
genes could affect any adaptive responses to 
lead through development and maturation and 
in later life (Jedrychowski et al. 2009).
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Ba c k g r o u n d: Lead exposure in adults is associated with hypertension. Altered prenatal nutrition is 
associated with subsequent risks of adult hypertension, but little is known about whether prenatal 
exposure to toxicants, such as lead, may also confer such risks.
oBjectives: We investigated the relationship of prenatal lead exposure and blood pressure (BP) in 
7- to 15-year-old boys and girls.
Me t h o d s : We evaluated 457 mother–child pairs, originally recruited for an environmental birth 
cohort study between 1994 and 2003 in Mexico City, at a follow-up visit in 2008–2010. Prenatal 
lead exposure was assessed by measurement of maternal tibia and patella lead using in vivo K-shell 
X-ray fluorescence and cord blood lead using atomic absorption spectrometry. BP was measured by 
mercury sphygmomanometer with appropriate-size cuffs.
re s u l t s: Adjusting for relevant covariates, maternal tibia lead was significantly associated with 
increases in systolic BP (SBP) and diastolic BP (DBP) in girls but not in boys (p-interaction with 
sex = 0.025 and 0.007 for SBP and DBP, respectively). Among girls, an interquartile range increase 
in tibia lead (13 μg/g) was associated with 2.11-mmHg [95% confidence interval (CI): 0.69, 3.52] 
and 1.60-mmHg (95% CI: 0.28, 2.91) increases in SBP and DBP, respectively. Neither patella nor 
cord lead was associated with child BP.
co n c l u s i o n s: Maternal tibia lead, which reflects cumulative environmental lead exposure and a 
source of exposure to the fetus, is a predisposing factor to higher BP in girls but not boys. Sex-specific 
adaptive responses to lead toxicity during early-life development may explain these differences.
key w o r d s : blood pressure, children, lead, prenatal exposure, sex. Environ Health Perspect 
120:445–450 (2012).  http://dx.doi.org/10.1289/ehp.1103736 [Online 27 September 2011]Zhang et al.
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In the present study, we capitalized on 
a long­running environmental birth cohort 
study to examine the relationship of prenatal 
lead exposure, assessed by both maternal bone 
and umbilical cord lead, with BP in 7­ to 
15­year­old children. We hypothesized that 
children of mothers with higher levels of lead 
accumulated in bone would have higher BP 
than would children of mothers with lower 
bone lead, and that this impact of lead on BP 
might differ according to child sex.
Materials and Methods
Study population. Mother–child pairs in this 
study were drawn from three of the four longi­
tudinal birth cohort studies in Mexico City that 
comprise the Early Life Exposures in Mexico to 
Environmental Toxicants (ELEMENT) proj­
ect. Subjects were originally recruited between 
1994 and 2003 to investigate the long­term 
consequences of prenatal exposure on child 
development (Gonzalez­Cossio et al. 1997; 
Tellez­Rojo et al. 2004). Detailed information 
on the study design and data collection proce­
dures has been published previously (Ettinger 
et al. 2009; Gonzalez­Cossio et al. 1997; 
Hernandez­Avila et al. 2002). Briefly, baseline 
information on health status and on social and 
demographic characteristics was collected from 
all eligible participants at delivery and 1 month 
postpartum. Anthropometric data from the 
mother and newborn, and umbilical cord and 
maternal venous blood samples were gathered 
within 12 hr of delivery. Information on esti­
mated gestational age, based on the date of last 
menstrual period, and characteristics of the 
birth and newborn period were extracted from 
the medical records. Maternal dietary energy, 
calcium, and iron intakes were calculated on 
the basis of a semiquantitative food­frequency 
questionnaire designed to estimate usual 
dietary intake over the prior month (Ettinger 
et al. 2009; Romieu et al. 1997). Interviewers 
explained the study to and obtained written 
consent from eligible women who were will­
ing to participate and provided information 
on ways to minimize lead exposure. Exclusion 
criteria included factors that could interfere 
with maternal calcium metabolism; medical 
conditions that could cause low birth weight; 
prematurity (< 37 weeks) or an infant with 
Apgar score at 5 min of ≤ 6, a condition 
requiring treatment in neonatal intensive care 
unit; birth weight < 2,000 g, or serious birth 
defects; psychiatric illness, seizures, or kidney 
or cardiac disease; preeclampsia, systolic BP 
(SBP) > 140 mmHg or diastolic BP (DBP) 
> 90 mmHg; gestational diabetes; consump­
tion of alcoholic beverages; addiction to illegal 
drugs; and continuous use of corticosteroids.
The mother–child pairs were contacted and 
recalled for the follow­up assessment between 
2008 and 2010 when the children were 7–15 
years of age. Only one child for each mother 
was included in this study, regardless of birth 
order. Medical history, physical examination, 
BP measurements, and venous blood samples 
were collected from or performed on mothers 
and children. Of 1,272 mother–child pairs 
who were eligible for this study, 631 (49.6%) 
attended the follow­up study evaluation. The 
most common reason for nonparticipation was 
the inconvenience of making the follow­up 
visit to the clinic. Of those participating in the 
follow­up visit, 457 (72.4%) completed the 
study with data on all variables of interest and 
were included in the analysis. At time of this 
visit, mothers and children old enough to pro­
vide assent to participate were given detailed 
information about present study procedures 
and signed a written letter of informed consent. 
The human subjects committees of all partici­
pating   institutions approved this research.
Lead measurements. Maternal tibia (cor­
tical) and patella (trabecular) bone lead lev­
els were measured within 1 month of delivery 
using a spot­source 109Cd K­shell X­ray fluo­
rescence (K­XRF) instrument (ABIOMED, 
Danvers, MA, USA)  (Hu et al. 1998). 
Umbilical cord blood lead was analyzed using 
an atomic absorption spectrometry instrument 
(model 3000; PerkinElmer, Chelmsford, MA, 
USA), and child concurrent blood lead was 
analyzed using inductively coupled plasma 
mass spectrometry (Elan 6100; PerkinElmer, 
Norwalk, CT, USA). Because of the logistical 
constraints posed by the collection of samples 
during birth from multiple hospitals and at 
unpredictable hours, as well as subject’s con­
cerns about venipuncture, we obtained data on 
lead levels in cord blood and current venous 
blood, respectively, from 323 (70.7%) and 367 
(80.3%) of children participating in this study.
Blood pressure end points. At the fol­
low­up assessment, BP was measured in both 
mothers and children. The mothers were 
instructed to abstain from smoking and from 
drinking alcohol and caffeine­containing bev­
erages and children from drinking caffeine­
containing beverages for at least 12 hr before 
coming to the study center. Immediately after 
the medical history review, while the subjects 
remained seated for an additional 5 min, the 
resting SBP and DBP of the mother and the 
child were measured by trained clinical per­
sonnel on the participant’s left arm using a 
standard mercury column sphygmomanom­
eter and a cuff of appropriate size.
Statistical analyses. Statistical analysis 
was carried out using SAS (version 9.2; SAS 
Institute Inc., Cary, NC, USA). We exam­
ined univariate distributions of all variables 
and descriptive statistics and identified outli­
ers before bivariate and multivariate analyses. 
Umbilical cord blood lead concentrations were 
transformed to their natural logarithmic values 
to normalize the right­skewed distribution. 
Differences between groups defined by child 
sex or missing cord lead were evaluated using 
t­tests for continuous variables and Pearson’s 
chi­square tests for categorical variables. 
Simple linear regression was used to quantify 
unadjusted associations between BP and cord 
or bone lead, as well as other covariates.
The adjusted associations between BP and 
cord or bone lead, as well as other covariates, 
Table 1. Characteristics of the study participants, overall and by child sex.
Variablea
Overall 




(n = 246) p-Valueb
Maternal characteristics during index pregnancy
Maternal age (years) 25.6 ± 5.4 25.7 ± 5.5 25.6 ± 5.3 0.56
Maternal education (years) 10.5 ± 3.0 10.3 ± 2.8 10.7 ± 3.2 0.39
Smoking during pregnancy (% yes) 3.5 4.3 2.8 0.16
Calories (kcal) 1.44 ± 0.58 1.45 ± 0.61 1.44 ± 0.56 0.75
Calcium (mg) 2,303 ± 708 2,313 ± 766 2,296 ± 657 0.80
Iron (mg) 20.7 ± 15.4 21.2 ± 15.2 20.2 ± 15.7 0.47
Tibia lead (μg/g) 9.3 (3.3–16.1) 9.99 (3.5–16.3) 9.1 (3.1–16) 0.33
Patella lead (μg/g) 11.6 (4.5–19.9) 10.8 (4.6–20.9)  12.2 (4.5–18.5) 0.92
Maternal characteristics during follow-up
SBP (mmHg) 109.9 ± 11.3 109.2 ± 11 109.3 ± 11 0.32
DBP (mmHg) 72 ± 8.4 71.5 ± 8.3 72.3 ± 8.3 0.74
Child characteristics at birth
Gestational age (weeks) 39 ± 1.3 38.9 ± 1.3 39.1 ± 1.3 0.69
Birth weight (g) 3,130 ± 432 3,066 ± 440 3,190 ± 418 < 0.01
Cord blood lead (μg/dL)c 5.51 ± 3.45 5.67 ± 3.67 5.48 ± 3.27 0.63
Child characteristics at follow-up
Age (years) 10.7 ± 2.4 10.6 ± 2.4 10.8 ± 2.4 0.79
Birth order 2.04 ± 1.13 2.03 ± 113 2.05 ± 113 0.82
Height (cm) 143 ± 14 142 ± 12 145 ± 15.4 < 0.01
BMI (kg/m2) 20 ± 3.9 19.7 ± 3.7 20.2 ± 4.1 0.15
Blood lead (μg/dL)d 2.96 ± 1.72 2.75 ± 1.66 3.55 ± 1.76 0.10
SBP (mmHg) 94.9 ± 10.5 94.6 ± 10.5 95 ± 10.5 0.66
DBP (mmHg) 61.4 ± 8.2 60.7 ± 8.4 61.5 ± 8.2 0.52
aValues are median (IQR) for bone lead, percentage for smoking during pregnancy, and mean ± SD for all other vari-
ables. bBased on t-tests or Pearson’s chi-square tests. cChildren with umbilical cord blood lead level, n = 323: 143 girls 
and 180 boys. dChildren with concurrent blood lead level, n = 367: 176 girls and 191 boys.Blood pressure, lead, and prenatal exposure
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were then assessed using multiple linear regres­
sion. Models for SBP and DBP were simul­
taneously fitted using generalized estimating 
equations to account for the correlation in 
these outcomes. Covariates were chosen based 
on biological plausibility or significant bivari­
ate associations with BP. A base model was fit­
ted that included maternal education (years), 
smoking (yes/no), dietary intakes of calories 
(kilocalories), calcium (milligrams), and iron 
(milligrams) during pregnancy; and infant ges­
tational age (weeks) and weight (kilograms) 
at birth, birth order, sex, and child’s concur­
rent age (years), height (centimeters), and 
body mass index (BMI; kilograms per square 
meter). Each exposure variable was added to 
the base model one at a time, and models were 
run in the combined sample (boys and girls) 
as well as stratified by sex. The final models 
were fitted in the combined sample, and a 
cross­product term was introduced to evalu­
ate the interaction of each lead exposure vari­
able with sex. We also examined the potential 
confounding effect of current lead exposure by 
further adjusting for child’s blood lead level 
at the follow­up visit. Additive models with 
smoothed terms for exposure were also esti­
mated to assess the nature of the association 
between lead exposure and BP. Partial residu­
als and estimated smoothed terms were plot­
ted. Because bone lead is also known to be 
associated with higher BP in women (Korrick 
et al. 1999; Rothenberg et al. 2002), and 
maternal BP is a risk factor for child’s BP and 
therefore may be in the causal pathway, we did 
not include maternal BP as a standard covari­
ate in the analyses. Instead, we conducted a 
sensitivity analysis by adjusting for maternal 
DBP, which is substantially heritable (Perusse 
et al. 1989; van Rijn et al. 2007) but relatively 
less affected by bone lead than is SBP (Navas­
Acien et al. 2008).
Results
Prenatal and later follow­up characteristics 
for mothers and their children are presented 
in Table 1. All of the 457 participant moth­
ers were Mexican, with a mean (± SD) age of 
25.6 ± 5.4 years (range, 19–31 years) at the 
time of the index child’s birth. The 1­month 
postpartum maternal tibia and patella 
bone lead had median [interquartile range 
(IQR)] values of 9.3 (3.3–16.1) and 11.6 
(4.5–19.9) μg/g, respectively. Umbilical cord 
blood lead had a mean of 5.51 ± 3.45 μg/
dL. The mean for available concurrent blood 
lead levels was 2.96 ± 1.72 μg/dL. Spearman 
correlations between any two exposure bio­
markers ranged from 0.10 to 0.36 (p < 0.05). 
The mean age of children at follow­up was 
10.7 ± 2.4 years (range, 7–15 years). The 
mean SBP and DBP were 94.9 ± 10.5 and 
61.4 ± 8.2 mmHg, respectively. Of the 457 
child participants, 46% were girls and 54% 
were boys. There were no significant differ­
ences between girls and boys for maternal 
bone or umbilical cord lead levels. Boys had 
slightly higher blood lead levels at the time 
of BP measurement than did girls (p = 0.10) 
(Table 1). Significant differences by sex, with 
higher mean values for boys, were observed 
for birth weight (p < 0.01) and height of chil­
dren at follow­up (p < 0.01). Girls were, on 
average, shorter by 3 cm (Table 1). No other 
differences by sex were observed.
In the simple linear regression analyses of 
non  lead covariates, children’s age, height, and 
BMI were significantly associated with SBP or 
DBP in both girls and boys (Table 2). Tibia 
lead was significantly associated with SBP 
in girls, whereas cord blood lead was signifi­
cantly associated with DBP in boys. Maternal 
age, dietary intake of calories, calcium, and 
iron during pregnancy, weight at birth, birth 
order, and child blood lead were not signifi­
cantly associated with BP.
In the base multivariate regression model 
(data not shown), with the combined sam­
ple, DBP was significantly associated with 
child age [0.75 mmHg; 95% confidence 
interval (CI): 0.14, 1.37 mmHg], BMI 
(0.37 mmHg; 95% CI: 0.16, 0.59 mmHg), 
and birth order (–0.66 mmHg; 95% CI: 
–1.26, –0.06 mmHg) and maternal edu­
cation (–0.23 mmHg; 95% CI: –0.49, 
0.02 mmHg). Although not statistically sig­
nificant, the associations between SBP and 
age, birth order, and maternal education were 
in the same direction as those for DBP; SBP 
was significantly associated with child BMI 
(0.76 mmHg; 95% CI: 0.47, 1.05 mmHg).
Adjusted tibia, patella, and cord blood 
lead were not significantly associated with 
SBP (Table 3). However, in sex­stratified 
analyses, significant associations between tibia 
lead and SBP or DBP were observed only 
among girls (data not shown). In final models 
that formally tested sex differences using inter­
action terms, we found significant interac­
tions between sex and tibia lead for child SBP 
and DBP (p­interaction = 0.025 and 0.006, 
respectively), indicating a stronger association 
of tibia lead with BP among females. Among 
girls, an IQR increase in maternal tibia lead 
(13 μg/g) was associated with 2.11­mmHg 
(95%  CI:  0.69,  3.52  mmHg)  and 
1.60­mmHg (95% CI: 0.28, 2.91 mmHg) 
Table 2. Parameter estimate (mean ± SD) from simple linear regression of child BP in relation to maternal lead biomarkers and other factors.
SBP DBP
Variable Overall (n = 457) Boys (n = 246) Girls (n = 211) Overall (n = 457) Boys (n = 246) Girls (n = 211)
Maternal characteristics during index pregnancy
Maternal age (years) 0.03 ± 0.09 0.03 ± 0.09 0.04 ± 0.09 –0.10 ± 0.1 –0.09 ± 0.1 –0.11 ± 0.1
Maternal education (years) –0.12 ± 0.2 –0.10 ± 0.2 –0.16 ± 0.2 –0.17 ± 0.1 –0.14 ± 0.1 –0.24 ± 0.1
Smoking during pregnancy (% yes) –0.91 ± 3.0 –0.86 ± 3.0 –1.01 ± 3.0 –2.0 ± 2.17 –1.88 ± 2.2 –2.27 ± 2.2
Calories (kcal) 0.58 ± 0.72 0.57 ± 0.75 0.59 ± 0.75 0.55 ± 0.50 0.70 ± 0.53 0.43 ± 0.52
Calcium (mg) –0.67 ± 0.9 –0.62 ± 0.9 –0.75 ± 1.0 –0.39 ± 0.7 –0.17 ± 0.7 –0.71 ± 0.73
Iron (mg) –0.16 ± 0.3 –0.05 ± 0.4 –0.28 ± 0.4 –0.09 ± 0.2 0.04 ± 0.27 –0.24 ± 0.25
Tibia lead (μg/g) 0.10 ± 0.0** 0.07 ± 0.06 0.13 ± 0.05** 0.05 ± 0.04 0.03 ± 0.05 0.07 ± 0.05
Patella lead (μg/g) 0.08 ± 0.04 0.08 ± 0.05 0.07 ± 0.05 0.04 ± 0.04 0.04 ± 0.04 0.026 ± 0.04
Maternal characteristics during follow-up
SBP (mmHg) 0.32 ± 0.04 0.32 ± 0.04 0.32 ± 0.04 0.20 ± 0.03 0.20 ± 0.03 0.19 ± 0.03
DBP (mmHg) 0.38 ± 0.06 0.38 ± 0.06 0.38 ± 0.06 0.29 ± 0.05 0.29 ± 0.05 0.29 ± 0.05
Child characteristics at birth
Gestational age (weeks) 0.30 ± 0.38 0.30 ± 0.38 0.30 ± 0.38 0.41 ± 0.31 0.41 ± 0.31 0.39 ± 0.31
Birth weight (g) 1.53 ± 1.28 1.53 ± 1.28 1.52 ± 1.35 1.3 ± 0.95 1.28 ± 0.95 1.09 ± 1.02
Birth order 0.05 ± 0.45 –0.13 ± 0.5 0.27 ± 0.50 –0.31 ± 0.3 –0.37 ± 0.4 –0.25 ± 0.38
Cord blood lead (μg/dL) 0.32 ± 0.18 033 ± 0.19 0.31 ± 0.22 0.26 ± 0.12** 0.28 ± 0.14** 0.24 ± 0.14
Child characteristics during follow-up
Child age (years) 1.49 ± 0.18* 1.48 ± 0.19* 1.52 ± 0.19* 1.19 ± 0.15* 1.2 ± 0.15* 1.18 ± 0.16*
Child height (cm) 0.25 ± 0.03* 0.25 ± 0.03* 0.25 ± 0.03* 0.19 ± 0.02* 0.19 ± 0.03* 0.19 ± 0.03*
Child BMI (kg/m2) 1.01 ± 0.13* 1.0 ± 0.13* 1.02 ± 0.12* 0.61 ± 0.10* 0.62 ± 0.10* 0.60 ± 0.10*
Child blood lead (μg/dL) 0.20 ± 0.13 0.22 ± 0.14 0.15 ± 0.20 –0.01 ± 0.2 0.03 ± 0.14 –0.10 ± 0.22
*p < 0.001, **p < 0.05, derived from testing linear regression coefficients. Zhang et al.
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increases in SBP and DBP, respectively. 
In contrast, tibia lead tended to be non­
significantly negatively associated with SBP 
(p = 0.68) and DBP (p = 0.18) among boys. 
The sex difference of the adjusted association 
between patella lead and BP was similar to 
that for tibia lead, but the relationship was 
not as strong or statistically significant (p­in­
teraction = 0.46 for SBP and 0.19 for DBP). 
Cord blood lead was not associated with SBP 
or DBP. There were no significant interac­
tions between sex and cord blood lead.
Additional adjustment for concurrent 
blood lead, in the sample with those measure­
ments available (n = 367), changed parameter 
estimates for maternal tibia lead by about 2% 
and 17.5% for SBP and DBP, respectively 
(Table 4), suggesting that concurrent blood 
lead is a negative confounder. The interaction 
between sex and tibia remained significant 
for DBP (p­interaction = 0.006) but was only 
marginally significant for SBP (p­interaction 
= 0.08). Further adjustment for maternal 
DBP reduced the effect estimate by 32%, as 
expected (data not shown).
Partial residuals of BP and tibia lead and 
the smoothed associations, overall and strati­
fied by child sex, are shown in Figure 1. There 
were no deviations from linearity among the 
overall group or among males. Although there 
appears to be a slight curvilinear relationship 
between tibia lead and SBP among girls, the 
association did not deviate from linearity 
(p = 0.09). The data are thus consistent with a 
linear dose response among females.
Discussion
This is the first study to examine the asso­
ciation of maternal bone lead, as a marker of 
prenatal exposure, with child BP. We exam­
ined children’s BP, which is an established 
precursor of hypertension, atherosclerosis, 
and left ventricular hypertrophy in adult­
hood (Daniels et al. 1998; Lauer and Clarke 
1989; Litwin et al. 2006) and also assessed the 
potential role of sex in modifying the response 
to prenatal lead exposure. In this prospective 
follow­up study, we observed positive associa­
tions between maternal tibia lead, not patella 
or umbilical cord blood lead, and both SBP 
and DBP among girls only. These sex­specific 
associations were independent of child’s ges­
tational age and weight at birth, birth order, 
age, and BMI and were not affected by mater­
nal smoking or dietary intakes of calories, 
calcium, or iron during pregnancy.
It has long been known that the prevalence 
of hypertension and CVD differs between 
men and women (McBride et al. 2005). 
However, a gap in knowledge remains regard­
ing the etiology of risk differences between the 
sexes (Pilote et al. 2007). Although genetic 
background and lifestyle may contribute, these 
factors do not fully explain the sex dichotomy 
in disease susceptibility.
Females may be at disproportionate risk 
to the developmental programming effects of 
prenatal exposure to lead. The association of 
tibia lead with child DBP in this study was 
attenuated after adjusting for maternal DBP, 
suggesting that maternal accumulated lead 
exposure may also program sex­specific adap­
tive responses via a maternal BP influence. 
Because pregnant women with chronic or 
gestational hypertension were excluded from 
our study, and their children may be at higher 
risk for higher BP, the associations of prenatal 
lead exposure with child BP could be under­
estimated in this study.
Our findings, if confirmed in larger stud­
ies, indicate that higher bone lead in women 
not only may result in increased risk of hyper­
tension in the women themselves (Korrick 
et al. 1999) but may also affect the subsequent 
cardiovascular health of their daughters. Our 
study highlights the need, besides continuing 
efforts to eliminate lead from and prevent lead 
release into environment, for secondary pre­
ventive measures, such as dietary calcium sup­
plementation (Ettinger et al. 2009), to reduce 
skeletal lead accumulation and resultant inter­
nal exposure through bone lead mobilization, 
especially in women of reproductive age.
One of the unique advantages of this study 
is that we measured maternal bone lead as a 
marker of cumulative lead exposure over the 
course of pregnancy. Levels of lead in mater­
nal tibia (9.3 μg/g) and patella (11.6 μg/g) 
in our subjects were similar to bone lead lev­
els reported previously in Mexican­American 
women (Rothenberg et al. 2002). In contrast 
to umbilical cord lead, which represents expo­
sure to the fetus around the time of deliv­
ery, maternal bone lead represents antenatal 
lead exposure even before conception. Lead 
accumulates in bone with a half­life on the 
order of years to decades and can persist many 
years after external sources of exposure have 
declined (Barbosa et al. 2005; Hu 1998). 
Substantial fetal lead exposure can occur from 
mobilization of cumulative maternal skeletal 
lead stores into the circulation during preg­
nancy (Hu 1998; Tellez­Rojo et al. 2004).
Tibia lead was more strongly associated 
with SBP and DBP than was patella lead. The 
patella consists mostly of trabecular bone and 
thus has a higher turnover rate than does the 
tibia, which consists mainly of cortical bone and 
has a longer half­life with respect to lead, and 
therefore better represents accumulated expo­
sure. Bone turnover is considered the major 
source of circulating lead in absence of ongoing 
external sources of exposure (Hu et al. 1998). 
Thus, patellar lead would be expected to exert 
the greatest impact on BP if the mechanism 
required only mobilization of bone lead stores 
Table 3. Adjusted difference [β-coefficient (95% CI)] in child BP for an IQR increase in maternal bone 
(n = 457) and cord blood lead (n = 323), overall and by sex.
Measure
Tibia lead 
(IQR = 13 μg/g)
Patella lead 
(IQR = 16 μg/g)
Cord blood lead 
(IQR = 4 μg/dL)
Overall 
SBP  0.96 (–0.13, 2.05)  0.44 (–0.72, 1.61)  0.92 (–0.55, 2.39) 
DBP 0.46 (–0.52, 1.33) 0.23 (–0.74, 1.20) 0.92 (–0.11, 1.95)
Girls 
SBP  2.11 (0.69, 3.52)**  0.87 (–0.75, 2.49) 0.75 (–1.13, 2.63) 
DBP 1.60 (0.28, 2.91)* 0.83 (–0.66, 2.31) 0.96 (–0.22, 2.15)
Boys 
SBP  –0.34 (–1.98, 1.30)  0.01 (–1.64, 1.65)  1.23 (–1.11, 3.56) 
DBP –0.83 (–2.05, 0.38) –0.38 (–1.56, 0.79) 0.84 (–0.91, 2.59)
All models were adjusted for maternal education; smoking during pregnancy; dietary intakes of calories, calcium, and 
iron during pregnancy; infant birth order; gestational age and weight at birth; and child age, height, and BMI at the time 
of BP measurement. 
*p = 0.007, **p = 0.025, derived from cross-product terms of sex and tibia lead. 
Table 4. Associations between prenatal lead exposure and BP further adjusted by current lead exposure. 
Measure
Tibia lead 
(IQR = 13 μg/g)
Patella lead 
(IQR = 16 μg/g)
Cord blood lead 
(IQR = 4 μg/dL)
Overall
SBP 1.22 (0.02, 2.42) 0.24 (–1.08, 1.55) 0.71 (–0.87, 2.30)
DBP 0.64 (–0.41, 1.68) –0.02 (–1.07, 1.04) 0.86 (–0.21, 1.92)
Girls
SBP 2.15 (0.62, 3.67)** 0.49 (–1.40, 2.38) 0.74 (–1.18, 2.67)
DBP 1.88 (0.45, 3.34)* 0.32 (–1.34, 2.0) 0.84 (–0.40, 2.09)
Boys
SBP 0.04 (–1.82, 1.90) 0.02 (–1.84, 1.81) 0.88 (–1.03, 2.80)
DBP –0.96 (–2.35, –0.44) –0.37 (–1.59, 0.85) 0.65 (–1.97, 3.27)
Parameter estimates represent the difference in child BP (mmHg) for an IQR increase in maternal bone (n = 367) and 
cord blood lead (n = 323), overall and by sex. All models adjusted as in Table 3 and with additional adjustment for child’s 
concurrent blood lead level at the time of BP measurement. 
*p = 0.005, **p = 0.08, derived from cross-product terms of sex and tibia lead.Blood pressure, lead, and prenatal exposure
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 3 | March 2012  449
during pregnancy. The observed association of 
long­lived tibia lead with girls’ BP leads us to 
speculate that the sex­specific lead impacts on 
adult disease programming might begin quite 
early in germ cell development and fetal life. 
Both our study and the Oswego Children’s 
Study (Gump et al. 2005) have revealed associ­
ations in children, but with different lead expo­
sure biomarkers (e.g., tibia lead vs. cord blood 
lead). In contrast to the Oswego Children’s 
Study, we found an association between chil­
dren BP and tibia lead but not with cord blood 
lead. The reason for this inconsistency may be 
attributable to differences in children’s ages and 
study locations and design, or adjustment for 
additional factors such as maternal depression 
or prenatal exposures to mercury and pesti­
cides that was not done in the present study. 
It is also noteworthy that the mean (± SD) 
cord blood lead in the present study (5.51 ± 
3.45 μg/dL) was nearly three times higher than 
that seen in Oswego Children’s Study (1.98 
± 1.75 μg/dL). Further studies are needed to 
clarify the   apparent discrepancy.
The biological pathway(s) that may under­
lie sex differences in the impact of prenatal lead 
exposure are not clear, but clues may be gained 
from known lead toxicity mechanisms in 
adults. Compared with boys and age­matched 
men, girls and premenopausal women have 
been reported to have lower BP and hyperten­
sion prevalence, but such differences disappear 
when women reach menopause (Dasgupta 
et al. 2006; McBride et al. 2005; Pilote et al. 
2007), suggesting that ovarian estrogen ste­
roids, via their roles in neural and hormonal 
regulations of BP, may protect women from 
hypertension and CVD. An impact of ovarian 
estrogen hormones on lead toxicity has been 
observed in studies where postmenopausal 
women were found to be more sensitive to 
hypertensive effects of lead than were premeno­
pausal women (Korrick et al. 1999; Nash et al. 
2003; Potula and Kaye 2006). Early stages of 
fetal development have more plasticity than 
during any other time in life and are sensitive 
to maternal–fetal stressors that can interfere 
with the natural hormones, neurotransmitters, 
and growth factors controlling development. 
Lead has been shown to interfere with estrogen 
metabolism by direct ovotoxicity and via indi­
rect effects on the hypothalamus–pituitary–
ovarian axis (Hoyer 2005). Prenatal exposure 
to lead, at environmentally relevant concen­
trations, has been found to decrease circulat­
ing estrogen levels in adult rats (Dearth et al. 
2002). It is biologically plausible that girls may 
be more sensitive to the hypertensive effects of 
prenatal lead exposure because of the interrup­
tion of estrogen metabolism.
Recently, our group reported that prena­
tal lead exposure is associated with decreased 
genomic DNA methylation (Pilsner et al. 
2009). The consistent changes in the DNA 
methylation of some imprinted and growth­
promoting genes have also been found to be 
associated with prenatal famine in humans, 
which depend on the sex of the child and ges­
tational timing of the exposure (Tobi et al. 
2009). As such, it is possible that the resulting 
epigenetic alterations may change developmen­
tal estrogenization and sex­specific susceptibil­
ity throughout the life course (Gabory et al. 
2009). Because hypertension is a polygenetic 
disorder, innate sex differences in the genetic 
susceptibility to lead toxicity, in addition to 
sex hormone–mediated attenuation of other 
sex­related common determinants, may also 
be involved in developmental programming 
(Gilbert and Nijland 2008). Further research is 
needed to examine whether those mechanism(s) 
are responsible for the apparent association of 
prenatal lead exposure with BP in females.
The present study has several limitations. 
Despite the standardized protocol, the single 
measure of BP using a mercury sphygmo­
manometer is prone to measurement error. 
Such errors are random, however, and pro­
mote attenuation of observed effects rather 
than the generation of spurious associations. 
Children’s BP is known to rise progressively 
with chronological age and body size and more 
rapidly in puberty (Leccia et al. 1999). It is 
possible that the observed impact of bone lead 
on BP in girls may be, in part, mediated by 
variation of age of onset of puberty, with girls 
reaching puberty 3 years earlier, on average, 
than boys. As described above, the birth cohort 
study conducted only one follow­up visit after 
early childhood (7–15 years) and was not spe­
cifically designed to assess sexual maturation. 
Therefore, the age of onset of puberty was not 
known. We examined this possibility by com­
paring impacts of maternal bone lead on child 
BP between girls 10–11 years of age and boys 
13–14 years of age and found that the appar­
ent sex difference within all participants was 
not substantially changed (data not shown). 
Previous studies indicate that lead levels as 
low as 3 μg/dL, and independent of body size, 
delay growth and pubertal development in girls 
(Selevan et al. 2003). Therefore, lead would 
likely be associated with decreased rather than 
increased BP, which is opposite to our find­
ings. Our study and others noted here do not 
support puberty as a potential confounder 
between lead and BP. However, we cannot 
rule out such a possibility based on these data. 
Assessments of sexual maturation are needed 
in future studies to delineate the true sex dif­
ferences. In addition, because child’s diet and 
physical activities were not measured, we could 
not determine whether the effects of bone lead 
are related to those general lifestyle factors. 
Finally, because our study was conducted in 
a Mexican population, the results may be not 
applicable to non­Hispanic ethnic groups.
Conclusion
Our results suggest that long­lived maternal 
bone lead stores acquired from previous envi­
ronmental lead exposure pose a risk of higher 
BP in girls but not boys. Thus, differences 
in BP observed between women and men 
across young and middle age may stem, at 
least partially, from increased likelihood of 
lead exposure during early­life development. 
Because elevated BP in childhood is a known 
risk for hypertension in adulthood, continu­
ing follow­up of these children over the years 
is warranted.
Figure 1. Partial residual plots of systolic blood pressure (SBP) and tibia lead levels, and smoothed terms (regression curve and 95% CI) derived from additive 
models for overall group (A), boys (B), and girls (C), adjusted for maternal education, smoking during pregnancy; dietary intakes of calories, calcium, and iron dur-
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